This document discusses an interactive discussion forum on ICH Q7 and Q11 guidelines for good manufacturing practices. The discussion focused on whether a drug product can ensure safety if manufactured from a non-compliant active pharmaceutical ingredient. Participants also considered whether good manufacturing practices are required for pharmaceutical ingredients, processes, and products.
1 of 8
Downloaded 10 times
More Related Content
ICHQ7 & Q11 (2 of 7)
1. Discussion Forum on ICH Q7 & Q11
Interactive Opening Discussion
Dr. Obaid Ali
Deputy Director, DRAP
Member ISPE, PDA
23 April 2017 (Program A)
21 May 2017 (Program B)